Eton Pharmaceuticals (ETON) awards director 10,000 performance RSUs
Rhea-AI Filing Summary
Adams Jennifer McKie reported acquisition or exercise transactions in this Form 4 filing.
Eton Pharmaceuticals director Jennifer McKie Adams received a grant of 10,000 performance‑vested restricted stock units under the 2018 equity incentive plan. Each unit represents one share, vesting only if the stock closes at $72.36 or higher for one trading day before July 31, 2029; otherwise the award is forfeited.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Adams Jennifer McKie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 10,000 shares (Direct)
Footnotes (1)
- F1. On July 31, 2026, the reporting person was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date. If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range.
Key Figures
RSU Grant Size: 10,000 units
Vesting Price Condition: $72.36 per share
Forfeiture Date: July 31, 2029
3 metrics
RSU Grant Size
10,000 units
Performance-vested restricted stock units granted July 31, 2026
Vesting Price Condition
$72.36 per share
Stock closing price required for one trading day for award to vest
Forfeiture Date
July 31, 2029
Award forfeited without consideration if price condition not met by this date
Key Terms
performance-vested restricted stock units, equity incentive plan, market condition
3 terms
performance-vested restricted stock units financial
"was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018"
equity incentive plan financial
"was granted 10,000 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
market condition financial
"If this market condition is not satisfied prior to such date, the award"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did ETON director Jennifer McKie Adams receive in this Form 4 filing?
Jennifer McKie Adams received 10,000 performance‑vested restricted stock units from Eton Pharmaceuticals. Each RSU represents the right to acquire one share of common stock, subject to a stock‑price performance condition and potential forfeiture if that condition is not met.
What performance condition applies to Jennifer McKie Adams’s 10,000 ETON RSUs?
The RSUs vest only if Eton’s stock closing price reaches or exceeds $72.36 per share for one trading day. This market condition must occur at any time before the third anniversary of the July 31, 2026 grant date.
When do Jennifer McKie Adams’s ETON RSUs expire if the condition is not satisfied?
If the $72.36 stock‑price condition is not met, the RSU award is forfeited in its entirety on July 31, 2029. No shares will be issued and no consideration will be paid if forfeiture occurs.
Was Jennifer McKie Adams’s ETON Form 4 transaction under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5‑1 checkbox is not marked, and there is no footnote describing a pre‑arranged trading plan. The reported grant therefore is not characterized as made under a Rule 10b5‑1 plan.
What plan governs the 10,000 RSU grant to ETON director Jennifer McKie Adams?
The 10,000 performance‑vested RSUs were granted under Eton Pharmaceuticals’ 2018 equity incentive plan. This plan provides the framework for equity‑based awards such as restricted stock units to directors and other eligible participants.